DB00078 | Ibritumomab tiuxetan | approved, investigational | yes | antibodyregulator | Details |
DB00081 | Tositumomab | approved, investigational | yes | antibody | Details |
DB00073 | Rituximab | approved | yes | antibodyregulator | Details |
DB06650 | Ofatumumab | approved | yes | antibodyregulator | Details |
DB08935 | Obinutuzumab | approved, investigational | yes | antibodyregulator | Details |
DB11988 | Ocrelizumab | approved, investigational | yes | antagonistantibody | Details |
DB09336 | Technetium Tc-99m nofetumomab merpentan | approved, withdrawn | yes | binder | Details |
DB11850 | Ublituximab | approved, investigational | yes | binderantibody | Details |
DB15434 | Mosunetuzumab | approved, investigational | yes | binder | Details |
DB16684 | Odronextamab | investigational | yes | binder | Details |
DB16371 | Glofitamab | approved, investigational | yes | binderantibody | Details |
DB16672 | Epcoritamab | approved, investigational | yes | binderantibody | Details |